BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33786711)

  • 1. Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.
    Yasunaga M; Yahata H; Okugawa K; Hori E; Kodama K; Yagi H; Ohgami T; Onoyama I; Asanoma K; Kato K
    Int J Clin Oncol; 2021 Jul; 26(7):1330-1335. PubMed ID: 33786711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.
    Feng Z; Wen H; Ju X; Bi R; Chen X; Yang W; Wu X
    J Surg Oncol; 2020 Aug; 122(2):315-319. PubMed ID: 32500598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer.
    Timmermans M; Sonke GS; Van de Vijver KK; Ottevanger PB; Nijman HW; van der Aa MA; Kruitwagen RFPM
    Int J Gynecol Cancer; 2019 Feb; 29(2):392-397. PubMed ID: 30665898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.
    Tajik P; van de Vrie R; Zafarmand MH; Coens C; Buist MR; Vergote I; Bossuyt PMM; Kenter GG
    Int J Gynecol Cancer; 2018 Mar; 28(3):453-458. PubMed ID: 29324537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer.
    Métairie M; Benoit L; Koual M; Bentivegna E; Wohrer H; Bolze PA; Kerbage Y; Raimond E; Akladios C; Carcopino X; Canlorbe G; Uzan J; Lavoué V; Mimoun C; Huchon C; Koskas M; Costaz H; Margueritte F; Dabi Y; Touboul C; Bendifallah S; Ouldamer L; Delanoy N; Nguyen-Xuan HT; Bats AS; Azaïs H
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters.
    Xiao Y; Linghu H
    Cancer Control; 2023; 30():10732748231159778. PubMed ID: 36815671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclassification of stage IV gastric cancer (IVa, IVb, and IVc) and prognostic significance of substages.
    Ma Y; Xue Y; Li Y; Lan X; Zhang Y; Zhang M
    J Gastrointest Surg; 2010 Mar; 14(3):484-92. PubMed ID: 19949998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
    Ataseven B; Harter P; Grimm C; Heitz F; Heikaus S; Traut A; Kahl A; Kurzeder C; Prader S; du Bois A
    Gynecol Oncol; 2016 Aug; 142(2):243-7. PubMed ID: 27208538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis for investigating the relationship between FIGO stage IVA/IVB and cytoreductive surgery with prognosis in epithelial ovarian cancer.
    Liu H; Luo M; Peng C; Huang J; Wang D; Huang J; Zhang G
    Front Oncol; 2023; 13():1103357. PubMed ID: 37564940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of different metastatic sites for patients with FIGO stage IVB endometrial cancer after surgery: A SEER database analysis.
    Li H; Zhang R; Chen C; Wu C; Lin H; Li J; Lin Z
    J Surg Oncol; 2020 Oct; 122(5):941-948. PubMed ID: 32682330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.
    Ataseven B; du Bois A; Harter P; Prader S; Grimm C; Kurzeder C; Schneider S; Heikaus S; Kahl A; Traut A; Heitz F
    Int J Gynecol Cancer; 2016 Nov; 26(9):1594-1600. PubMed ID: 27654263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification.
    Paik ES; Lee YY; Lee EJ; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    Obstet Gynecol Sci; 2015 Mar; 58(2):124-34. PubMed ID: 25798426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.